ARCHIVES

DCCP Board Okays Concepts For Severn Contract Recompetitions, Denies Two Other

This article is from The Cancer Letter archive.

Vol. 07 No. 25 | June 19, 1981

Download PDF Visit The Full Archive

Related Articles

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

Lung Cancer Incidence Decreases Significantly In White Males For First Time In At Least 30 Years

December 6, 1985

Interview with FDA’s Richard Pazdur

October 30, 2009

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

Medical Oncology Fosters Long Term Relationships

May 5, 1989

NCAB Members Urge More Action In Support Of NCI.

December 15, 2006